Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young TIL with or without 12Gy TBI for Metastatic Melanoma
NCT01319565Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2011
- Primary completion
- Sep 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of young tumor-infiltrating lymphocytes in melanoma, sponsored by National Cancer Institute. Started Mar 2011; status: completed.
02
Drugs
young tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01319565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319565.